David E. Cohen
-
- Diet, Metabolism, and Disease 12
- Biochemistry top 0.2%
- Lipid metabolism and biosynthesis 28
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 42
- Cancer Research top 1%
- Physiology top 0.5%
- Adipose Tissue and Metabolism 32
- Diet and metabolism studies 13
-
- Drug Transport and Resistance Mechanisms 41
-
- Cholesterol and Lipid Metabolism 29
-
- Peroxisome Proliferator-Activated Receptors 20
- Co-authors
- Michele Alves‐BezerraYuki KawanoErez ScapaMartin C. CareySamir SofticAnn–Hwee LeeLaurie H. GlimcherC. Ronald Kahn
- Journals
- Journal of Lipid Research (17 papers)Hepatology (12 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (11 papers)
- Partner nations
- United StatesJapanIsrael
In The Last Decade
David E. Cohen
170 papers receiving 11.7k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Endocrinology, Diabetes and Metabolism 2.2k
- Biochemistry 897
- Epidemiology 4.0k
- Cancer Research 1.5k
- Physiology 2.5k
Countries citing papers authored by David E. Cohen
This map shows the geographic impact of David E. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Cohen more than expected).
Fields of papers citing papers by David E. Cohen
This network shows the impact of papers produced by David E. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Cohen. The network helps show where David E. Cohen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David E. Cohen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2023 | 8 | |
| 3 | 2022 | 25 | |
| 4 | 2020 | 19 | |
| 5 | 2020 | 15 | |
| 6 | 2020 | 97 | |
| 7 | 2020 | 46 | |
| 8 | 2017 | 261 | |
| 9 | 2016 | 8 | |
| 10 | 2016 | 37 | |
| 11 | Lipid and Lipoprotein Metabolism in Liver Disease | 2015 | 22 |
| 12 | MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasisbreakdown → | 2010 | 780 |
| 13 | 2010 | 17 | |
| 14 | 2007 | 26 | |
| 15 | 2007 | 42 | |
| 16 | 2006 | 278 | |
| 17 | 2002 | 2 | |
| 18 | 2002 | 74 | |
| 19 | 2001 | 242 | |
| 20 | 1996 | 23 |
About David E. Cohen
David E. Cohen is a scholar working on Biochemistry, Physiology, Oncology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 173 papers that have together received 12.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (42 papers), Drug Transport and Resistance Mechanisms (41 papers), Adipose Tissue and Metabolism (32 papers), Cholesterol and Lipid Metabolism (29 papers), Lipid metabolism and biosynthesis (28 papers), Peroxisome Proliferator-Activated Receptors (20 papers), Diet and metabolism studies (13 papers) and Diet, Metabolism, and Disease (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.2k citations), Biochemistry (897 citations), Epidemiology (4.0k citations), Cancer Research (1.5k citations) and Physiology (2.5k citations). David E. Cohen has collaborated with scholars based in United States, Japan and Israel. Frequent co-authors include Michele Alves‐Bezerra, Yuki Kawano, Erez Scapa, Martin C. Carey, Samir Softic, Ann–Hwee Lee, Laurie H. Glimcher, C. Ronald Kahn, Yingxia Li and Naga Chalasani. Their work appears in journals such as Journal of Lipid Research, Hepatology, American Journal of Physiology-Gastrointestinal and Liver Physiology, Journal of Biological Chemistry and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.